Category - Feature

Feature

Helius Medical rolling out PoNS treatment for mmTBI in Canada

Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is transitioning from a development- to commercial-stage company as it rolls out its Health Canada-cleared PoNS medical device for the treatment of chronic balance...

July 2, 2019

Feature

Chardan president, Jonas Grossman, talks SPACs

By Abby Hardy As president of Chardan, an independent, global investment bank specializing in healthcare, disruptive technologies, and special purpose acquisition companies (SPACs), Jonas Grossman takes a worldwide view...

June 25, 2019

Feature

Zenabis sets sights on becoming leading cannabis producer

By Len Zehr Despite being a new entrant in the cannabis market, Zenabis Global (TSX:ZENA) is making huge strides to become one of the largest licensed producers of medical and adult-use recreational cannabis in Canada...

June 11, 2019

Feature

Oragenics developing novel therapeutics using synthetic bacteria

By Abby Hardy Oragenics (NYSE American: OGEN) is leveraging its synthetic biology platforms to address two significant unmet medical needs: oral mucositis (OM) and multi drug-resistant (MDR) bacterial infections...

May 28, 2019

Feature

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

By Len Zehr BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) has reported impressive early safety and efficacy data with its lead immunotherapies for the treatment of advanced breast cancer. “Right now, there is no...

May 21, 2019

Feature

MediXall transforming patient-healthcare provider experience

By Len Zehr MediXall Group (OTCQB:MDXL) has launched a new generation healthcare marketplace platform to address self-pay and high deductible consumers’ growing need for greater healthcare cost transparency and access...

May 14, 2019

Feature

Ceapro transitioning to biopharmaceutical company from contract manufacturer

By Len Zehr Ceapro (TSXV:CZO) is transitioning to a new business model – from a contract manufacturer to a biopharmaceutical company – to pursue multiple growth opportunities in nutraceuticals and...

May 7, 2019

Feature

Leviticus Cardio developing wireless system to drive VADs

Michael Zilbershlag, Co-Founder and CEO By Len Zehr Closely-held Leviticus Cardio of Israel is developing a wireless system capable of providing day-to-day power needs for implanted ventricular assist devices (VADs)...

April 30, 2019

Feature

In conversation with Susan Linna of BDO

Susan Linna, Managing Director Life Sciences Specialty Services at BDO By Len Zehr As managing director, life sciences specialty services at BDO, the global professional services firm, Susan Linna has more than 25 years...

April 23, 2019

Feature

CellMax developing first blood test for CRC preventative screening

Padma Sundar, VP of Strategy and Market Access By Len Zehr Closely-held CellMax Life has developed FirstSightCRC, the first blood test to identify precancerous adenomas, with accuracy similar to colonoscopies, when...

April 16, 2019

Category - Feature

Helius Medical rolling out PoNS treatment for mmTBI in Canada

Chardan president, Jonas Grossman, talks SPACs

Zenabis sets sights on becoming leading cannabis producer

Oragenics developing novel therapeutics using synthetic bacteria

BriaCell advancing potential breakthrough immunotherapy for advanced breast cancer

MediXall transforming patient-healthcare provider experience

Ceapro transitioning to biopharmaceutical company from contract manufacturer

Leviticus Cardio developing wireless system to drive VADs

In conversation with Susan Linna of BDO

CellMax developing first blood test for CRC preventative screening

General

More